首页> 美国卫生研究院文献>Yonago Acta Medica >Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents
【2h】

Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents

机译:抗吸收剂治疗的患者下颌骨骨密度或骨密度的系统指标与抗吸收剂相关的下颌骨坏死的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundSome previous studies have examined anti-resorptive agent-related osteonecrosis of the jaw (ARONJ) prediction using systemic markers of bone turnover as risk factors. Radiographic imaging is also effective at detecting ARONJ. In this study, computed tomography (CT)-derived bone mineral density (BMD) values and the levels of systemic markers of bone turnover were evaluated, and then each parameter was compared between patients that developed ARONJ and those who did not after treatment with systemic anti-resorptive agents. The aim of this study was to determine whether systemic markers of bone turnover and/or BMD values can be used to predict the risk of ARONJ
机译:背景以前的一些研究已经使用骨转换的系统性标志物作为危险因素来检查与抗再吸收剂相关的下颌骨坏死(ARONJ)的预测。射线照相成像对检测ARONJ也有效。在这项研究中,对计算机断层扫描(CT)得出的骨矿物质密度(BMD)值和骨转换的全身性标记物水平进行了评估,然后比较了患有ARONJ的患者和未接受全身性治疗的患者的每个参数抗吸收剂。这项研究的目的是确定是否可以使用骨转换和/或BMD值的系统性标志物来预测ARONJ的风险

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号